![](/img/cover-not-exists.png)
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes
Mathieu, Chantal, Catrinoiu, Doina, Ranetti, Aurelian Emil, Johnsson, Eva, Hansen, Lars, Chen, Hungta, Garcia-Sanchez, Ricardo, Iqbal, Nayyar, Celiñski, AleksanderLanguage:
english
Journal:
Diabetes Therapy
DOI:
10.1007/s13300-018-0445-x
Date:
May, 2018
File:
PDF, 506 KB
english, 2018